![]() |
|
|
BE Huber
Division of Experimental Therapy, Wellcome Research Laboratories, Research Triangle Park, North Carolina 27709.
The major and minor forms of the asialoglycoprotein receptor (ASGP-R), designated in the rat as RHL-1 and RHL-2/3, respectively, have traditionally been considered to be expressed exclusively in hepatic parenchymal cells. Northern blot analysis now demonstrates that rat and mouse testis express a receptor similar to the RHL-1 ASGP-R but not the RHL-2/3 receptor. In situ hybridization studies demonstrate that late- stage mouse and rat spermatids are the testicular cells that express the RHL-1 ASGP-R. The rat spermatid RHL-1 receptor has functional binding capability, with a KD of approximately 1.4 x 10(-8) M, and similar characteristics, compared with the hepatic RHL-1 receptor, regarding ligand binding specificity and ion dependence. These findings have major implications for therapeutic procedures attempting to target cytotoxic agents or DNA to hepatocytes using the ASGP-R. In addition, these findings demonstrate that late-stage spermatids are transcriptionally active and suggest that the RHL-1 receptor may have a functional role in sperm maturation and/or fertilization.
This article has been cited by other articles:
![]() |
E. I. Park, S. M. Manzella, and J. U. Baenziger Rapid Clearance of Sialylated Glycoproteins by the Asialoglycoprotein Receptor J. Biol. Chem., February 7, 2003; 278(7): 4597 - 4602. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rohlff, S. A. Watson, T. M. Morris, L. Skelton, A. L. Jackman, and M. J. Page A Novel, Orally Administered Nucleoside Analogue, OGT 719, Inhibits the Liver Invasive Growth of a Human Colorectal Tumor, C170HM2 Cancer Res., March 1, 1999; 59(6): 1268 - 1272. [Abstract] [Full Text] [PDF] |
||||